Adjunctive early hydrocortisone therapy does not prevent the development of septic shock in patients with severe sepsis
The Hydrocortisone for Prevention of Septic Shock (HYPRESS) study was published in JAMA on Oct 3, 2016. 380 patients with sepsis (with evidence of infection plus at least 2 systemic inflammatory response syndrome criteria and evidence of organ dysfunction ) were randomized either to receive a continuous infusion of 200 mg of hydrocortisone for 5 days or placebo. There … Read more